Skip to main content
. 2012 Jun 12;44(15):754–763. doi: 10.1152/physiolgenomics.00027.2012

Table 2.

Distribution of demographic characteristics for subjects in the Vlagtwedde-Vlaardingen cohort

Nondecliners (n = 300) Fast Decliners (n = 233) P Value
Men/Women 215/85 162/71 0.590
Age, yr 49.7 ± 9.6 53.05 ± 9.7 <0.0001
Smoking history, pack-years* 23.5 ± 16.8 29.4 ± 19.0 <0.0001
ΔFEV1/yr, % predicted pre 0.9 ± 0.7 −0.5 ± 0.5 <0.0001
ΔFEV1/yr, % predicted post NA NA
Baseline FEV1, % predicted pre§ 96.2 ± 15.1 100.6 ± 14.7 0.001
Baseline FEV1, % predicted post NA NA

Values are means ± SD for continuous data.

*

Number of packs of cigarettes smoked per day/number of years smoking.

Change in lung function over the total period someone was in the study per year as % predicted FEV1 prebronchodilator.

Change in lung function over the total period someone was in the study per year as % predicted FEV1 postbronchodilator.

§

Lung function at the start of the Vlagtwedde/Vlaardingen as measured by FEV1(%) predicted prebronchodilator.

Lung function at the start of the Vlagtwedde/Vlaardingen as measured by FEV1(%) predicted postbronchodilator.